Common Stock, Shares, Issued of Renalytix plc from 30 Jun 2018 to 30 Sep 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Renalytix plc quarterly Common Stock, Shares, Issued in shares history and change rate from 30 Jun 2018 to 30 Sep 2024.
  • Renalytix plc Common Stock, Shares, Issued for the quarter ending 30 Sep 2024 was 165,925,513, a 77% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

Renalytix plc Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 165,925,513 +72,144,035 +77% 30 Sep 2024 10-Q 19 Nov 2024 2025 Q1
Q2 2024 154,368,191 +60,586,713 +65% 30 Jun 2024 10-Q 19 Nov 2024 2025 Q1
Q1 2024 119,916,187 +26,134,709 +28% 31 Mar 2024 10-Q 15 May 2024 2024 Q3
Q4 2023 99,930,156 +25,038,312 +33% 31 Dec 2023 10-Q 14 Feb 2024 2024 Q2
Q3 2023 93,781,478 +18,889,634 +25% 30 Sep 2023 10-Q 14 Nov 2023 2024 Q1
Q2 2023 93,781,478 +19,021,046 +25% 30 Jun 2023 10-K 30 Sep 2024 2024 FY
Q1 2023 93,781,478 +91,352,790 +3761% 31 Mar 2023 6-K 09 Jun 2023
Q4 2022 74,891,844 +2,582,914 +3.6% 31 Dec 2022 6-K 30 Mar 2023
Q3 2022 74,891,844 30 Sep 2022 6-K 30 Nov 2022
Q2 2022 74,760,432 +2,563,146 +3.6% 30 Jun 2022 10-K 28 Sep 2023 2023 FY
Q1 2022 2,428,688 31 Mar 2022 10-K 28 Sep 2023 2023 FY
Q4 2021 72,308,930 31 Dec 2021 6-K/A 29 Apr 2022
Q2 2021 72,197,286 +12,781,152 +22% 30 Jun 2021 20-F 31 Oct 2022 2022 FY
Q2 2020 59,416,134 +5,600,000 +10% 30 Jun 2020 20-F/A 01 Aug 2022 2021 FY
Q2 2019 53,816,134 +33,816,134 +169% 30 Jun 2019 20-F/A 10 Nov 2020 2020 FY
Q2 2018 20,000,000 30 Jun 2018 20-F/A 10 Nov 2020 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.